AfoliOpen Afoli →

Erlosamide

Erlosamide is an active ingredient of the class «anticonvulsant agent».

Open in Afoli Medicines →

Anticonvulsant compound

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

VIMPAT is indicated for: Treatment of partial-onset seizures in patients 1 month of age and older Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older 1.1 Partial-Onset Seizures VIMPAT is indicated for the treatment of partial-onset…

US label

Vimpat is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.

EMA

How it works

Class: anticonvulsant agent

Common side effects

The following serious adverse reactions are described below and elsewhere in the labeling: Suicidal Behavior and Ideation Dizziness and Ataxia Cardiac Rhythm and Conduction Abnormalities Syncope Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity Reactions Adjunctive therapy…

US label

Pregnancy and breastfeeding

Exposure Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (AEDs), such as VIMPAT, during pregnancy.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Motpoly XR · Vimpat

European Union

Lacosamide Accord · Lacosamide Adroiq · Lacosamide UCB · Vimpat

Canada

Alembic-Lacosamide · Apo-Lacosamide · Auro-Lacosamide · Jamp-Lacosamide · Mint-Lacosamide · Pharma-Lacosamide · Riva-Lacosamide · Sandoz Lacosamide · Teva-Lacosamide · Vimpat · Zds-Lacosamide

Approval status

US Food and Drug Administration
prescription · since 2008
European Medicines Agency
authorised · since 2008
Health Canada
prescription · marketed
First approval anywhere
2008

Codes

ATC
N03AX18
RxNorm CUI
623400
ChEMBL
CHEMBL58323
PubChem CID
219078
UNII
563KS2PQY5
Wikidata
Q420077

Frequently asked questions

What is Erlosamide used for?

Erlosamide is used for: Epilepsy, Focal epilepsy, and Seizure.

What kind of medicine is Erlosamide?

Erlosamide is an active ingredient of the class «anticonvulsant agent».

What are the brand names of Erlosamide?

Brand names of Erlosamide include Motpoly XR, Vimpat, Lacosamide Accord, Lacosamide Adroiq, Lacosamide UCB, Alembic-Lacosamide, Apo-Lacosamide, and Auro-Lacosamide.

Medicines in the same class

Sources and licences

Updated November 15, 2026